Tue, Sep 23, 2014, 11:08 AM EDT - U.S. Markets close in 4 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • dr.kuvasz dr.kuvasz Oct 22, 2010 1:14 PM Flag

    OGXI Closes 50 Million Public Offering

    It has closed. net proceeds of 46.7 million.

    The company announced it will use proceeds "to advance its product pipeline, including its lead program, custirsen, and 427, which is currently in clinical development as a treatment for prostate and bladder cancer, as well as for general corporate purposes".

    Well, that explanation is good enough for me. Bringing 011 in prostate and lung to market, as well as 427 in prostate and bladder, will make this a multi billion dollar company. We also need some stability in the interim. I hope the growth of a stable investor base will accomplish this objective.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • >Well, that explanation is good enough for me. Bringing 011 in prostate and lung to market, as well as 427 in prostate and bladder

      Well. O11 is externally funded. 427 Prostate is externally funded. A P2 study for bladder wont cost a lot. So what are going to do with the rest of the $90M+? So I think they have something else in mind. The CC is next week. What are we going to hear? Couple more P2 studies for 427? A surprise? Buying full 427 or O11 rights from ISIS? Or was this just a normal precaution to keep the co going in case O11 fails?

 
OGXI
2.86+0.01(+0.35%)11:04 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.